Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.49 USD | -2.46% | +8.70% | +4.93% |
03-13 | Top Premarket Decliners | MT |
03-12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- ITOS Stock
- Revisions iTeos Therapeutics, Inc.